Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2009
06/25/2009CA2709749A1 3-substituted-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]-tetrazine-8-carboxylic acid amides and their use
06/25/2009CA2709407A1 Anthelmintic agents and their use
06/25/2009CA2709176A1 Reverse transcriptase inhibitors
06/25/2009CA2709119A1 Preventive or therapeutic agent for inflammatory bowel diseases
06/25/2009CA2708361A1 Novel imidazo[1,2-a]pyridine and imidazo[1,2-b]pyridazine derivatives
06/25/2009CA2707456A1 Spiroindolinone derivatives
06/24/2009EP2072518A1 Stable Amorphous Form of Pemextred Disodium
06/24/2009EP1954698B1 Spirocyclic compounds as hdac inhibitors
06/24/2009EP1863812A4 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
06/24/2009CN101466714A Purinone derivatives as HM74A agonists
06/24/2009CN101463036A Preparation method and use of Penicillium chrysogenum amide
06/24/2009CN101463035A Improved method for producing anagrelide hydrochloride monohydrate
06/24/2009CN100503610C Benzoporphyrin chlorophyll photosensitizer and its preparation process and use
06/24/2009CN100503609C 2-alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine a2a receptor antagonists
06/24/2009CN100503604C Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests
06/24/2009CN100503580C Irreversible inhibitor of tyrosine kinase
06/24/2009CN100503566C Inhibitors of cytosolic phospholipase A2
06/23/2009US7550590 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance
06/23/2009US7550588 Homotropanes with central nervous system activity
06/23/2009US7550587 Photosensitizer and method for production thereof
06/23/2009US7550586 Phthalocyanines with peripheral siloxane substitution
06/23/2009US7550503 Macrolide compounds comprising 18,19-epoxytricosa-8,12,14-trien-11-olide derivatives; angiogenesis inhibitors; anticarcinogenic, antimetastasis, antiinflammatory, and antitumor agents; antihypoxic agents; endothelial growth factor suppressors; retinal neovascularization, diabetic retinopathy
06/23/2009US7550494 Small molecules useful in the treatment of inflammatory disease
06/23/2009US7550474 Anticoagulants; strokes; restenosis; antiinflamamtory agents
06/23/2009US7550471 5-alkyl-7-aminotriazolopyrimidines, methods and intermediary product necessary for the production thereof, agents containing said compounds and the use thereof for fighting against harmful mushrooms
06/23/2009US7550470 Substituted pyrazolo[1,5-A]pyrimidines as tyrosine kinase inhibitors
06/23/2009US7550464 Use of phosphodiesterase 4 inhibitors such as 8,9-dimethoxy-6-phenyl-1,3,4,6,11,11a-hexahydro-2H -pyrazino[1,2-b]isoquinoline for treating asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis
06/23/2009US7550461 Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases
06/23/2009US7550038 Poly cross-linked phthalocyanine compound and near-infrared absorbing ink composition comprising the same
06/23/2009CA2522220C Cgrp receptor antagonists
06/23/2009CA2504735C Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
06/23/2009CA2492804C Novel inhibitors of kinases
06/23/2009CA2420694C Guanidinobenzamides as mc4-r agonists
06/18/2009WO2009076593A1 Modulators of cystic fibrosis transmembrane conductance regulator
06/18/2009WO2009076352A1 Gamma secretase modulators
06/18/2009WO2009076337A1 Gamma secretase modulators
06/18/2009WO2009075323A1 Stable crystal of β-lactam compound
06/18/2009WO2009074743A1 Pyrazolo-pyrazines derivatives used as g protein inhibitors
06/18/2009WO2009074677A2 Pyrazolotriazines
06/18/2009WO2009074575A2 Organic compounds
06/18/2009WO2009074259A1 Triazolotriazines and triazolopyrazines and the use thereof
06/18/2009WO2009056077A3 A new method of manufacturing 2-(6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-lh-pyrrolizine-5-yl)acetic acid (licofelone)
06/18/2009WO2009047104A3 Pyrrolopyrrole derivatives, their manufacture and use
06/18/2009WO2009037394A3 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof
06/18/2009WO2009025919A3 5-propargyl-pyrimidine derivatives as inhibitors of dihydrofolate reductase with antibacterial antiprotozoal, antifungal and anticancer properties
06/18/2009WO2009010298A3 Paullone derivatives and its use
06/18/2009WO2008056266A8 Substituted 8-piperidinyl-2-pyridinyl-pyrimido [1,2-a]pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido[1,2-a]pyrimidin-6-one derivatives
06/18/2009WO2007124337A8 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1
06/18/2009US20090156813 Methods of preparing aripiprazole crystalline forms
06/18/2009US20090156799 Methods of making dyes
06/18/2009US20090156618 1-(1- (2-Ethoxyethyl)-3-Ethyl-7-(4-Methylpyridin-2-Ylamino) - 1H-Pyrazolo [4,3-D] Pyrimidin-5-YL) Piperidine-4-Carboxylic acid and salts thereof
06/18/2009US20090156617 Tyrosine kinase inhibitors
06/18/2009US20090156607 2-oxo-1-pyrrolidine derivatives
06/18/2009US20090156604 Fused bicyclic imidazoles
06/18/2009US20090156594 Heterocyclic kinase modulators
06/18/2009US20090156591 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors
06/18/2009US20090156583 Tricyclic Amide Derivatives
06/18/2009US20090156578 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
06/18/2009US20090156574 N-(4-(5-Butyl-2-methoxyphenyl)-1,3-thiazol-2-yl)-4-((4-oxopiperidin-1-yl)carbonyl)benzamide; antiinflammatory, anticarcinogenic, antidiabetic, analgesic agents
06/18/2009US20090156572 Nitrogen-containing heterocyclic compound and use thereof
06/18/2009US20090156558 Phosphonate analogs of antimetabolites
06/18/2009US20090156557 Kinase inhibitors
06/18/2009US20090156555 Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors
06/18/2009US20090156398 Fungicidal 5-alkyl-6-phenylpyrazolopyrimidin-7-ylamines
06/18/2009US20090155209 Novel macrocyclic inhibitors of hepatitis c virus replication
06/18/2009US20090153035 Heteroaromatic cycle-containing compound, method of preparing the same and organic light emitting device comprising the same
06/18/2009CA2845454A1 Organic compounds useful as inhibitors of phosphodiesterase 1
06/18/2009CA2709301A1 Modulators of cystic fibrosis transmembrane conductance regulator
06/18/2009CA2708783A1 Triazolotriazines and triazolopyrazines and the use thereof
06/18/2009CA2708300A1 Gamma secretase modulators
06/18/2009CA2708151A1 Gamma secretase modulators
06/18/2009CA2707857A1 Organic compounds
06/18/2009CA2700599A1 Pyrazolo-pyrazines derivatives used as g protein inhibitors
06/17/2009EP2070932A1 Pyrazolotriazines
06/17/2009EP2069353A1 Polycyclic agents for the treatment of respiratory syncytial virus infections
06/17/2009EP2069352A2 Certain chemical entities, compositions and methods
06/17/2009EP2069351A2 Pyrazoloquinazolinones as parp inhibitors
06/17/2009EP2069350A2 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
06/17/2009EP2069349A2 Pyrazolopyrimidines as cyclin dependent kinase inhibitors
06/17/2009EP2069348A2 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
06/17/2009EP2069347A2 Novel inhibitors of beta-lactamase
06/17/2009EP1789419B1 Gyrase inhibitors and uses thereof
06/17/2009EP1773822B1 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
06/17/2009EP1740591B1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
06/17/2009EP1735320B1 Compounds and methods for treating dyslipidemia
06/17/2009EP1628958B1 Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine
06/17/2009EP1620437B1 5,7-diaminopyrazolo¬4,3-d pyrimidines useful in the traetment of hypertension
06/17/2009EP1608653B1 SUBSTITUTED 8-PERFLUOROALKYL-6,7,8,9-TETRAHYDROPYRIMIDO (1,2- a) PYRIMIDIN-4-ONE DERIVATIVES
06/17/2009EP1566384B1 Novel azole derivatives
06/17/2009EP1542990B1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors
06/17/2009EP1485381B1 Azolylaminoazine as inhibitors of protein kinases
06/17/2009EP1435957B1 Inhibitors of gsk-3 and crystal structures of gsk-3beta protein and protein complexes
06/17/2009CN101460501A Pyrrolo[3,2-d]pyrimidin-4-one derivative as myeloperoxidase inhibitor
06/17/2009CN101460500A 3-substituted N-(aryl- or heteroaryl)-pyrazo[1,5-a]pyrimidines as kinase inhibitors
06/17/2009CN101460499A Deazapurines useful as inhibitors of JANUS kinases
06/17/2009CN101456862A Phenylguanidine derivates containing pyrazolo pyrimidinone, medicament composition thereof as well as preparation method and application thereof
06/17/2009CN100502087C 场致发光器件 Electroluminescent device
06/17/2009CN100500667C Tetrabenzothiazolyl porphyrin metal complex
06/17/2009CN100500666C Triazole pyrimidine sulphonates compound, preparing method and application thereof
06/17/2009CN100500665C Triazolo-pyrimido-thioacetamide compounds, preparation method and uses